Found 10 results

Name Type of Offering Accepted Date
Lung Therapeutics, Inc. See All Filings
D/A 2017-02-24 12:01:42
Amount To Be Raised $17,000,000
Associated Brokers / Dealers N/A
CIK Number 0001611241
Filed Document 0001209191-17-014159
Exclusions or Exemptions 506b
Accepted Date 2017-02-24 12:01:42
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Lung Therapeutics, Inc. See All Filings
D 2018-06-18 10:04:32
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001611241
Filed Document 0001209191-18-038227
Exclusions or Exemptions 506b
Accepted Date 2018-06-18 10:04:32
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Option To Acquire
Lung Therapeutics, Inc. See All Filings
D 2016-03-07
Amount To Be Raised $6,000,000
Associated Brokers / Dealers N/A
CIK Number 0001611241
Filed Document 0001209191-16-106855
Exclusions or Exemptions 506b
Accepted Date 2016-03-07
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Lung Therapeutics, Inc. See All Filings
D 2019-05-24 13:35:18
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001611241
Filed Document 0001209191-19-032648
Exclusions or Exemptions 506b
Accepted Date 2019-05-24 13:35:18
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Lung Therapeutics, Inc. See All Filings
D 2014-09-10
Amount To Be Raised $2,568,912
Associated Brokers / Dealers N/A
CIK Number 0001611241
Filed Document 0001209191-14-057237
Exclusions or Exemptions 506b
Accepted Date 2014-09-10
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Lung Therapeutics, Inc. See All Filings
D/A 2015-09-30
Amount To Be Raised $2,568,912
Associated Brokers / Dealers N/A
CIK Number 0001611241
Filed Document 0001209191-15-072531
Exclusions or Exemptions 506b
Accepted Date 2015-09-30
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Lung Therapeutics, Inc. See All Filings
D/A 2017-05-19 14:23:12
Amount To Be Raised $14,333,859
Associated Brokers / Dealers N/A
CIK Number 0001611241
Filed Document 0001209191-17-033871
Exclusions or Exemptions 506b
Accepted Date 2017-05-19 14:23:12
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Lung Therapeutics, Inc. See All Filings
D/A 2018-07-25 17:42:19
Amount To Be Raised $3,855,000
Associated Brokers / Dealers N/A
CIK Number 0001611241
Filed Document 0001209191-18-043929
Exclusions or Exemptions 506b
Accepted Date 2018-07-25 17:42:19
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Option To Acquire
Lung Therapeutics, Inc. See All Filings
D/A 2019-10-31 10:16:16
Amount To Be Raised $38,682,750
Associated Brokers / Dealers N/A
CIK Number 0001611241
Filed Document 0001209191-19-054587
Exclusions or Exemptions 506b
Accepted Date 2019-10-31 10:16:16
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Lung Therapeutics, Inc. See All Filings
D 2022-04-04 15:07:36
Amount To Be Raised $15,000,000
Associated Brokers / Dealers N/A
CIK Number 0001611241
Filed Document 0001209191-22-022263
Exclusions or Exemptions 506b
Accepted Date 2022-04-04 15:07:36
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity